Community Center

Stanford IM residency program director, Cardiologist, Specialist in Amyloidosis, Cardio-Oncology, and Advanced heart failure.

BSIM's mission is to deliver quality drug candidates with high capital efficiency against transthyretin-mediated amyloidosis, including clinical manifestations and…

Twitter Handle: Director, Cardiac Amyloidosis Program, Brigham and Women's Hospital and Harvard Medical School.

SOM Biotech is a clinical-stage drug discovery and development company based in Barcelona, Spain, with an office in the US, focused on repurposing drugs for CNS…

The official Twitter for the Brigham and Women's Hospital Amyloidosis Program.

Prothena Corporation plc is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally…

As the leader in RNA-targeted drug discovery and development, Ionis has created an efficient, broadly applicable, proprietary antisense technology platform with the…

Amyloidosis is a rare disease that manifests itself when amyloid protein deposits accumulate in the body's organs and tissues, ultimately causing organ failure if…

This page is to offer positive support to the family members, friends and caregivers of loved ones with amyloidosis.

Supporting #amyloidosis patients and families while promoting research, education and awareness.